U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07176416) titled 'Effective Phaco Time and Endothelial Cell Loss When Using Veritas' on Sept. 09.
Brief Summary: This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Cataract
Intervention:
DEVICE: Veritas Vision System
Veritas Vision System
Recruitment St...